| |


Published:
Journal of Analytical Toxicology,
ISSN 0146-4760,
Volume 32, Number 3, April,
pp.208-219
An Enantiomer-Selective
Liquid Chromatography–Tandem Mass Spectrometry Method for
Methadone and EDDP Validated for Use in Human Plasma, Urine, and
Liver Microsomes
David E. Moody1, Shen-Nan Lin1,
Yan Chang1, Lolita Lamm1, Mark
K. Greenwald2, and Mahmoud S. Ahmed3
1Center for Human Toxicology, Department of Pharmacology and Toxicology,
University of Utah, Salt Lake City, Utah 84108;
2Substance Abuse
Research Division, Department of Psychiatry and Behavioral Neurosciences,
Wayne State University, Detroit, Michigan 48207; and
3Department
of Obstetrics and Gynecology, University of Texas Medical Branch,
Galveston, Texas 77555
A liquid chromatography–electrospray ionization-tandem
mass spectrometry method has been developed and validated to
detect (R)- and (S)-methadone and (R)- and (S)-2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
(EDDP) in human plasma with cross-validation to urine and liver
microsomes. Use of deuterated internal standards and liquid–liquid
extraction coupled with chiral separation provided baseline separation
with a lower limit of quantitation (LLOQ) of 2.5 ng/mL. The LLOQ
was established from comparison of signal in blanks from six
different sources per matrix with the same sources fortified
at the LLOQ (none exceeded 19% of LLOQ) and precision and accuracy
at the LLOQ determined in the same six sources per matrix. The
assay was precise (% coefficients of variation within 13.8%)
and accurate (% targets within 15%) in all three matrices. No
interference was seen from addition of other psychoactive drugs.
Stability was determined in plasma (24 h at room temperature,
321 days at –20°C, 3 freeze-thaw cycles); processed
plasma samples (5 days at –20°C, 12 days on autosampler);
urine (24 h at room temperature); and stock solutions (20 h at
room temperature, 61 days at –20°C). Applications of
varying degree are presented for each matrix. Plasma from five
subjects maintained on 100 mg oral methadone per day permitted
comparison of the pharmacokinetics of the enantiomers. The t1/2
of (R)-methadone was significantly longer than for (S)-methadone,
and (S)-methadone was more tightly protein bound. The Cmax,
AUC, Cmin, and % protein bound of (S)-EDDP were significantly
greater than (R)-EDDP, while the t1/2 of (R)-EDDP
was significantly greater than (S)-EDDP. In spot urines, (R)-
was higher than (S)-methadone, and (S)- was generally higher
than (R)-EDDP. (R)- and (S)-EDDP production was detected after
incubation of therapeutic concentrations of racemic methadone
with human liver microsomes, and (S)-EDDP production was twofold
greater than (R)-EDDP in three human placental microsomes incubated
with racemic methadone.
Reproduction
of editorial content of this journal is prohibited without publishers
permission.
This
article is available in its entirety by fax for $4.00 per
page.
Visa or MasterCard accepted. To order electronically click here
or call: 847-647-2900 ext. 1323
or fax request to: 847-647-1155.
Please indicate JAT
volume and issue along with page numbers. |
|
Home | Subscribe
| Current Issue | Back Issues
| Search | Advertise | Other Publications
| |